Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth ...

Designed as easy-to-swallow pills, Aqua Sculpt ensures that every user, whether 18 or 80, with a busy or relaxed schedule, ...

The Ghana Health Service (GHS) has expressed worry about rising cases of overweight and obesity in children. Mr Joseph Owusu Asante, a nutritionist at the Nutrition Unit of the Bono Regional Health ...

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

New research reveals that obesity, having a knee injury and occupational risks such as shift work and lifting heavy loads are primary causes of knee osteoarthritis.

City Hall chiefs point finger at poor work-life balance as stark health data emerges, prompting a new initiative to create a ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

England's obesity crisis continues to deepen despite billions spent on treatment and prevention, new data shows.Nearly a ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...

New studies have shown that, unlike previously thought, obseity does not play a role in obstructed sleep apnea ...